Jewana

Aspadol 100mg, containing the active ingredient tapentadol, is a prescription medication designed to manage moderate to severe pain in adults. Its unique dual mechanism of action provides effective analgesia, making it a valuable option for individuals seeking rapid pain relief.​

Mechanism of Action

Tapentadol operates through two primary pathways:​

Mu-Opioid Receptor Agonism: Tapentadol binds to mu-opioid receptors in the central nervous system, altering the perception of pain and providing analgesic effects.​

Norepinephrine Reuptake Inhibition: By inhibiting the reuptake of norepinephrine, tapentadol enhances the descending inhibitory pain pathways, contributing to its analgesic properties.​

This dual mechanism distinguishes tapentadol from traditional opioids and may result in a different side effect profile.​

Indications

Aspadol 100mg is indicated for the management of moderate to severe acute pain in adults when alternative treatment options are inadequate. It is particularly useful in scenarios where pain is not adequately controlled by non-opioid analgesics or when such medications are not tolerated.​

Dosage and Administration

The recommended starting dose for Aspadol 100mg is one tablet every 4 to 6 hours, depending on the intensity of pain. The maximum daily dose should not exceed 600 mg. Patients should swallow the tablet whole with water, with or without food. It is crucial not to crush, chew, or dissolve the tablet, as this can lead to rapid release and absorption of a potentially fatal dose.​

Contraindications

Aspadol 100mg is contraindicated in individuals with:​

Significant respiratory depression​

Acute or severe bronchial asthma without resuscitative equipment​

Known or suspected gastrointestinal obstruction, including paralytic ileus​

Hypersensitivity to tapentadol or any component of the product​

Patients with severe hepatic impairment should not use tapentadol, as it may lead to increased exposure and adverse effects.​

Drug Interactions

Combining Aspadol 100mg with certain medications can result in serious interactions:​

Monoamine Oxidase Inhibitors (MAOIs): Concurrent use can lead to severe, unpredictable reactions. A 14-day gap is recommended between discontinuation of MAOIs and initiation of tapentadol therapy.​

Central Nervous System (CNS) Depressants: Co-administration with other CNS depressants, such as benzodiazepines, other opioids, or alcohol, can enhance sedative effects and increase the risk of respiratory depression, coma, or death.​

Serotonergic Drugs: Combining tapentadol with serotonergic medications, including selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), or tricyclic antidepressants, may increase the risk of serotonin syndrome, a potentially life-threatening condition.​

Warnings and Precautions

Addiction, Abuse, and Misuse: Tapentadol has a high potential for addiction, abuse, and misuse, which can lead to overdose and death. Prescribe and dispense Aspadol 100mg cautiously, especially in patients with a history of substance abuse.​

Life-Threatening Respiratory Depression: Serious, life-threatening, or fatal respiratory depression may occur. Monitor patients closely, especially upon initiation or following a dose increase.​

Accidental Ingestion: Accidental ingestion, especially by children, can result in a fatal overdose.​

Neonatal Opioid Withdrawal Syndrome: Prolonged use during pregnancy can result in neonatal opioid withdrawal syndrome, which may be life-threatening if not recognized and treated promptly.​

Head Injuries: Tapentadol may elevate intracranial pressure, posing risks for individuals with head injuries, brain tumors, or other conditions that increase intracranial pressure.​

Use in Specific Populations

Pregnancy: Tapentadol is classified as pregnancy category C. There are no adequate and well-controlled studies in pregnant women. Use only if the potential benefit justifies the potential risk to the fetus.​

Lactation: It is unknown whether tapentadol is excreted in human milk. Due to potential serious adverse reactions in nursing infants, decide whether to discontinue nursing or the drug.​

Pediatric Use: Safety and effectiveness in pediatric patients have not been established.​

Geriatric Use: Elderly patients may have increased sensitivity to tapentadol. Monitor closely for respiratory depression and other adverse effects.​

Overdose Management

In case of overdose, primary attention should focus on re-establishing adequate respiratory exchange through provision of a patent airway and institution of assisted or controlled ventilation. Administer opioid antagonists, such as naloxone, to counteract the effects. Continuous monitoring is essential, as the duration of action of tapentadol may exceed that of the antagonist.​

Storage and Disposal

Store Aspadol 100mg tablets at room temperature, away from moisture and heat. Keep out of reach of children and pets. Dispose of unused or expired tablets through authorized take-back programs or consult your pharmacist for proper disposal methods.​

Patient Counseling Information

Patients should be informed about the following:​

Proper Use: Take Aspadol 100mg exactly as prescribed. Do not adjust the dose without consulting your healthcare provider.​

Avoid Alcohol: Consuming alcohol while taking tapentadol can result in dangerous side effects or death.​

Operating Machinery: Tapentadol may impair thinking and reactions. Avoid driving or operating heavy machinery until you know how the medication affects you.​

Potential for Abuse: Keep the medication in a secure